| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Hamilton James C72 | Chief Discovery/ Trans Medicine | Sell | 7,940 | $36.89 | $292,903.60 | -1.8% | -29.5% | -49.2% | |
| Jan 11, 2024 | Given Douglas B66 | Director | Sell | 2,911 | $38.06 | $110,788.36 | -1.1% | -32.3% | -50.7% | |
| Jan 11, 2024 | Waddill William D.50 | Director | Sell | 3,934 | $38.07 | $149,758.54 | -3.9% | -32.3% | -50.7% | |
| Jan 11, 2024 | Ferrari Mauro71 | Director | Sell | 3,147 | $38.06 | $119,786.60 | -2.5% | -32.3% | -50.7% | |
| Jan 11, 2024 | Vakiener Victoria53 | Director | Sell | 4,720 | $38.10 | $179,813.40 | -6.8% | -32.3% | -50.7% | |
| Jan 5, 2024 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sell | 16,104 | $35.27 | $567,909.60 | -1.2% | -26.7% | -44.4% | |
| Jan 5, 2024 | San Martin Javier65 | Chief Medical Officer | Sell | 8,303 | $35.26 | $292,803.92 | -1.3% | -26.7% | -44.4% | |
| Jan 5, 2024 | Oliver Tracie70 | Chief Commercial Officer | Sell | 74 | $33.89 | $2,507.86 | - | -26.7% | -44.4% | |
| Jan 5, 2024 | O'Brien Patrick76 | COO And General Counsel | Sell | 33,190 | $34.36 | $1,140,362.32 | -1.0% | -26.7% | -44.4% | |
| Jan 5, 2024 | Hamilton James C72 | Chief Discovery/ Trans Medicine | Sell | 38,443 | $34.69 | $1,333,528.95 | -2.6% | -26.7% | -44.4% |